Table 2.
Biopsy findings | Initial biopsy | Interval biopsy |
---|---|---|
(n = 59) | (n = 59) | |
Total glomeruli (n) | 19 (13–27) | 19 (13–24) |
Glomeruli (%) | ||
Normal | 26 (17–48) | 39 (21–60)* |
Necrotizing lesions | 25 (12–52) | 0 (0–0)* |
Cellular crescents | 16 (0–33) | 0 (0–0)* |
Fibrocellular crescents | 0 (0–14) | 0 (0–0)* |
Globally sclerosed | 7 (0–18) | 22 (9–40)* |
Interstitial inflammation | ||
Nil | 0 (0%) | 11 (19%)* |
Mild | 43 (73%) | 40 (68%) |
Moderate | 8 (14%) | 7 (12%) |
Severe | 8 (14%) | 1 (2%)* |
IFTA | ||
Mild | 32 (54%) | 21 (36%)* |
Moderate | 17 (29%) | 19 (32%) |
Severe | 10 (17%) | 19 (32%) |
Data are presented as median (interquartile range) or number of patients (%). Total glomeruli data are presented as number of glomeruli in sample. All other glomeruli data are presented as percentage of normal glomeruli. Analysis by Wilcoxon matched-pairs signed rank test or χ2 test as appropriate, *P <0.05. IFTA: interstitial fibrosis and tubular atrophy.